ArticleInternational journal of clinical pharmacy2021
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
Article in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Letter to the Editor regarding "Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample".International journal of clinical pharmacy · 2026Article
- Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community-Recruited Study.Drug and alcohol review · 2026Article
- Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West Virginia.Substance use & addiction journal · 2026Article
- Daily Doses of Gabapentinoids for Pain Management Among Opioid Users Aged Below and Above 65 years.Clinical medicine & research · 2026Article
- Prevalence and Patterns of Non-Medical Gabapentinoid Use in a General Population Sample: Findings From the Australian National Drug Strategy Household Survey.Drug and alcohol review · 2026Article
- A hospital-based multi-centric observational study to explore the prevalence and correlates of non-medical use and dependence of pregabalin among the patients with substance use disorder in Punjab & Chandigarh.Substance abuse treatment, prevention, and policy · 2026Observational
- A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016-2024.The International journal on drug policy · 2026Article
- The association between chronic medical health conditions and Delta-8 THC use among U.S. Adults.Journal of substance use · 2025Article
- A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies.Current drug research reviews · 2025Review
- Trends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study.CNS drugs · 2024Article
- Sexual HIV transmission risk behaviors associated with stimulant drug injection among people who non-medically use gabapentin and opioids.Journal of substance use · 2024Article
- Misuse of gabapentinoids (pregabalin and gabapentin) in patients with neuropathic pain related to spinal cord injury.The journal of spinal cord medicine · 2023Article
- Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States.Drug and alcohol dependence · 2023Article
- Quetiapine and olanzapine misuse prevalence in a US general population sample.The mental health clinician · 2023Article
- Pregabalin use in forensic hospitals and prisons in German speaking countries-a survey study of physicians.Frontiers in public health · 2023Article
- Overdose deaths involving non-BZD hypnotic/sedatives in the USA: Trends analyses.Lancet regional health. Americas · 2022Article
- Toxicological Relevance of Pregabalin in Heroin Users: A Two-Year Postmortem Population Study.Journal of analytical toxicology · 2022Article
- Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update".Drugs · 2021Article
- Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries.Frontiers in psychiatry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Reports of gabapentinoid (gabapentin and pregabalin) misuse are on the rise, but few studies have assessed this within the general US population. Objective Describe lifetime misuse/abuse/non-prescribed obtainment of gabapentinoids and descriptive characteristics associated with such actions in a US general population sample. Setting This cross-sectional questionnaire was administered online by Qualtrics
Indexed as
Identifiers
33387188What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.